- Joined
- Apr 21, 2011
- Messages
- 3,627
- Reaction score
- 9,284
Agreed. Demand for rad oncs is probably buoyed by about 25% just based on the abundance of caution that most exercise with the supervision rule. If the CMS rule was ever fully clarified (I honestly don't think it's altogether unclear as is currently) it could decimate the job market overnight. It's hard to say if bundled payments would lead to more hospitals trying to find alternative supervision options. I think IGRT is probably the most uncertain portion of having a non-rad onc physician or non-physician provider supervise daily treatments in the hospital setting, but if that's all bundled into a single, static reimbursement, what then?It would probably help reduce the number of candidates matching into the specialty if they understand how much work is being supported by the supervision requirements.
I think information symmetry would be a good thing here